MMSI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Merit Medical Systems Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 85.01 USD
14.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 17.6% above the Trend Line and sits at 72.2% of its 52-week range. The latest completed week returned 14.4%, after a 19.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is bullish with 48/100 conviction, while the latest news-sentiment score is 58/100.

Setup score 55 out of 100
Latest Close 85.01 USD 31 Jul 2026
1W Return 14.4% latest completed week
4W Return 19.6% short-term follow-through
12W Return 38.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 14.4% Latest completed week; four-week move 19.6%. Indicator stack 0/74 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 48/100 conviction; expected move 5.1%. News sentiment 58/100 56 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 17.6% above the Trend Line and sits at 72.2% of its 52-week range. The latest completed week returned 14.4%, after a 19.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2512-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.25Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 19.6% over four weeks, 38.7% over 12 weeks, and 0.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W14.4%
4W19.6%
12W38.7%
26W4.8%
52W0.3%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.13Latest activity-pressure read.
Pressure change51.6%Four-week change in activity pressure.
Leadership-1.03Latest relative-leadership reading.
RS change95.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum19/100Medium-term price momentum. Underlying universe rank 82; rank 1 is best.
Growth72/100Revenue and earnings growth. Underlying universe rank 29; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework39/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
31.8x
Price divided by trailing earnings.
Price / sales
2.9x
Market value relative to trailing revenue.
EV / EBITDA
13.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
48.7%
Gross profit retained from each unit of revenue.
Operating margin
13.8%
Operating profit retained from revenue.
Free-cash-flow margin
24.6%
Free cash flow generated from revenue.
Return on invested capital
8.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
11.2%
Latest one-year revenue growth.
EPS growth
14.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
39.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
-0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

MMSI shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.11, expected move of 5.1%, and Sharemaestro trend signal inactive.

Conviction48/100
Expected move5.1%
Put/call volume0.11
Pressure88
Speculation30
Volatility39
Trend agreement0
Open options detail
Insider activity15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 56 relevant articles.

24 positive · 29 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move5.1%Nearest-chain priced movement where available.
52-week drawdown-10.3%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+14.4%Week of 31 Jul.
Worst week-9.6%Week of 1 May.
Latest week+14.4%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains12
Flat weeks0
Modest losses7
Sharp losses4
Recent vol4.1%13-week weekly-return volatility.
Base vol4.0%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis23/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.25; No reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 75; Small Cap Core rank 84 SVQF39/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 440.5 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options45/100

MMSI shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.11, expected move of 5.1%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 5.1% Sentiment58/100

Weighted news tone is neutral across 56 relevant articles.

Merit Medical Systems Q2 Earnings Call Highlights Insiders15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202685.01 USD14.4%72.27 USD83.52 USD1.13-1.037.4MOff
24 Jul 202674.32 USD0.4%72.32 USD83.44 USD0.89-13.403.2MOff
17 Jul 202673.99 USD0.7%72.76 USD83.43 USD1.01-15.693.6MOff
10 Jul 202673.44 USD3.3%73.21 USD83.48 USD0.88-20.313.2MOff
3 Jul 202671.09 USD-0.9%73.66 USD83.56 USD0.74-22.272.8MOff
26 Jun 202671.73 USD6.7%74.07 USD83.61 USD0.48-21.705.8MOff
19 Jun 202667.22 USD1.0%74.56 USD83.69 USD-0.09-30.643.4MOff
12 Jun 202666.53 USD3.2%75.23 USD83.78 USD-0.46-30.394.2MOff
5 Jun 202664.48 USD2.3%75.85 USD83.89 USD-0.81-31.813.5MOff
29 May 202663.06 USD-1.7%76.62 USD84.01 USD-0.93-37.123.1MOff
22 May 202664.17 USD4.6%77.43 USD84.15 USD-0.86-35.062.9MOff
15 May 202661.36 USD0.1%78.05 USD84.26 USD-0.88-38.014.6MOff
8 May 202661.27 USD-1.2%78.73 USD84.41 USD-0.90-39.175.2MOff
1 May 202662.01 USD-9.6%79.33 USD84.56 USD-1.05-36.016.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.